Calisagan, Liezel .

HRN: 19-62-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2026
AMPICILLIN 1GM (VIAL)
06/14/2026
06/21/2026
IV
2 Grams
Q6
Promx 30 Mins
Checking Initial Appropriateness 
06/15/2026
CEFUROXIME 500MG (TAB)
06/15/2026
06/22/2026
PO
500mg
BID
RMLE
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: